Replies to post #386461 on Anavex Life Sciences Corp (AVXL)

[Doc328]

Yes, 6 in the lecanemab group and 7 in the placebo group during the phase 3. At least 2 more in the OLE for lecanemab but probably some non-ICH deaths in both groups. Age was 50-90 at entry --- some deaths will occur.